MARKET

NTHI

NTHI

NeOnc Technologies Holdings Inc
NASDAQ
5.42
-0.06
-1.09%
After Hours: 5.45 +0.03 +0.55% 17:13 05/20 EDT
OPEN
5.49
PREV CLOSE
5.48
HIGH
5.55
LOW
5.35
VOLUME
50.94K
TURNOVER
--
52 WEEK HIGH
12.99
52 WEEK LOW
3.200
MARKET CAP
140.99M
P/E (TTM)
-1.6918
1D
5D
1M
3M
1Y
5Y
1D
Alliance Global Partners Initiates Coverage of NeOnc Technologies Holdings (NTHI) with Buy Recommendation
NASDAQ · 1d ago
Maxim Group, Alliance Global, BTIG initiate coverage of NeOnc Technologies
PUBT · 1d ago
NeOnc Technologies Price Target Announced at $13.00/Share by Alliance Global Partners
Dow Jones · 1d ago
Alliance Global Partners Initiates Coverage On NeOnc Technologies Hldgs with Buy Rating, Announces Price Target of $13
Benzinga · 1d ago
NeOnc Technologies initiated with a Buy at Alliance Global
TipRanks · 1d ago
NEONC TECHNOLOGIES HOLDINGS INC <NTHI.O>: ALLIANCE GLOBAL PARTNERS INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $13
Reuters · 1d ago
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Reuters · 1d ago
NeOnc Advances Glioma Programs and Strengthens Financial Position
TipRanks · 2d ago
More
About NTHI
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Webull offers Neonc Technologies Holdings Inc stock information, including NASDAQ: NTHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTHI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTHI stock methods without spending real money on the virtual paper trading platform.